Description
NDC: 70512-865-15
Phenylephrine HCl 2.5% Ophthalmic Solution, 15 mL — Sola Pharmaceuticals
| Active ingredient | Phenylephrine hydrochloride 2.5% |
| Dosage form | Ophthalmic solution |
| Route | Topical ophthalmic |
| Size | 15 mL |
| Manufacturer | Sola Pharmaceuticals |
| NDC | 70512-865-15 |
Indications and Usage
An alpha-1 adrenergic receptor agonist indicated to dilate the pupil, for use in procedures requiring mydriasis.
Dosage and Administration
For patients 1 year of age and older, apply one drop to the conjunctival fornix at 3 to 5 minute intervals, up to a maximum of 3 drops per eye. In infants under 1 year of age, only the 2.5% strength should be used.
Warnings and Precautions
- Carries lower cardiovascular risk than the 10% strength but caution is still warranted
- Monitor blood pressure in patients with cardiovascular disease or hyperthyroidism
- Rebound miosis may occur the day after instillation
- Systemic absorption may cause blood pressure elevation in susceptible patients
Contraindications
None.
Adverse Reactions
Ocular reactions include eye pain and stinging on instillation, temporary blurred vision, and photophobia; systemic blood pressure elevation may occur in susceptible patients.
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F). Keep container tightly closed and protect from light and excessive heat.
How Supplied
Supplied as a sterile ophthalmic solution, 15 mL in a bottle.
Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.
